Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.33%

Published 03/08/2018, 03:25 PM
Updated 03/08/2018, 03:25 PM
© Reuters.  U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.33%

Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the Consumer Goods, Healthcare and Utilities sectors led shares higher.

At the close in NYSE, the Dow Jones Industrial Average rose 0.33%, while the S&P 500 index gained 0.39%, and the NASDAQ Composite index added 0.41%.

The best performers of the session on the Dow Jones Industrial Average were Johnson & Johnson (NYSE:JNJ), which rose 1.74% or 2.24 points to trade at 131.28 at the close. Meanwhile, Caterpillar Inc (NYSE:CAT) added 1.47% or 2.22 points to end at 153.73 and Pfizer Inc (NYSE:PFE) was up 1.49% or 0.53 points to 36.46 in late trade.

The worst performers of the session were International Business Machines (NYSE:IBM), which fell 1.47% or 2.32 points to trade at 156.00 at the close. Intel Corporation (NASDAQ:INTC) declined 1.13% or 0.58 points to end at 50.74 and UnitedHealth Group Incorporated (NYSE:UNH) was down 0.71% or 1.60 points to 224.92.

The top performers on the S&P 500 were Express Scripts Holding Co (NASDAQ:ESRX) which rose 7.82% to 79.16, Akamai Technologies Inc (NASDAQ:AKAM) which was up 6.70% to settle at 74.68 and Wynn Resorts Limited (NASDAQ:WYNN) which gained 6.47% to close at 179.31.

The worst performers were Kroger Company (NYSE:KR) which was down 11.84% to 23.12 in late trade, Cigna Corporation (NYSE:CI) which lost 11.31% to settle at 172.28 and L Brands Inc (NYSE:LB) which was down 5.59% to 41.51 at the close.

The top performers on the NASDAQ Composite were Jaguar Health Inc (NASDAQ:JAGX) which rose 117.71% to 0.305, Immuron Ltd ADR (NASDAQ:IMRN) which was up 65.55% to settle at 14.27 and InVivo Therapeutics Holdings (NASDAQ:NVIV) which gained 60.17% to close at 0.84.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The worst performers were Vascular Biogenics Ltd (NASDAQ:VBLT) which was down 61.03% to 2.650 in late trade, FTD Companies Inc (NASDAQ:FTD) which lost 34.74% to settle at 4.41 and Regulus Therapeutics Inc (NASDAQ:RGLS) which was down 26.59% to 0.918 at the close.

Rising stocks outnumbered declining ones on the New York Stock Exchange by 1731 to 1380 and 46 ended unchanged; on the Nasdaq Stock Exchange, 1376 rose and 1124 declined, while 103 ended unchanged.

Shares in Akamai Technologies Inc (NASDAQ:AKAM) rose to 52-week highs; gaining 6.70% or 4.69 to 74.68. Shares in Vascular Biogenics Ltd (NASDAQ:VBLT) fell to all time lows; falling 61.03% or 4.150 to 2.650. Shares in FTD Companies Inc (NASDAQ:FTD) fell to all time lows; falling 34.74% or 2.34 to 4.41.

The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was down 6.02% to 16.69.

Gold Futures for April delivery was down 0.42% or 5.60 to $1322.00 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in April fell 1.39% or 0.85 to hit $60.30 a barrel, while the May Brent oil contract fell 0.76% or 0.49 to trade at $63.85 a barrel.

EUR/USD was down 0.86% to 1.2304, while USD/JPY rose 0.12% to 106.22.

The US Dollar Index Futures was up 0.66% at 90.15.

Latest comments

This is fantastic.
This is very cool !
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.